Reducing costs and improving hypertension management

Canadian Journal of Clinical Pharmacology

Volumn 16, Issue 1, 2009, Pages

  Stankus, Vida ^a   Hemmelgarn, Brenda ^b   Campbell, Norm R C ^b   Chen, Guanmin ^b   McAlister, Finlay A ^a   Tsuyuki, Ross T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Adherence; Combination products; Cost savings; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST PLUS DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR PLUS THIAZIDE DIURETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CANADA; COST CONTROL; COST OF ILLNESS; DRUG MIXTURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEALTH CARE COST; HUMAN; HYPERTENSION; PRESCRIPTION; CLINICAL PRACTICE; COMPARATIVE STUDY; DRUG COMBINATION; ECONOMICS; FACTUAL DATABASE; PATIENT COMPLIANCE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CANADA; COST SAVINGS; DATABASES, FACTUAL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 61949301985     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Khan NA, Hemmelgarn B, Herman RJ et al; for the Canadian Hypertension Education Program. The 2008 Canadian Hypertension Education Program (CHEP) recommendations for the management of hypertension: Part 2-Therapy. Can J Cardiol 2008;24(6):465-476.
2. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.
3. Hansson L, Zanchetti A, Carruthers SG et al; for the HOT Study Group. Effects of intensive blood- pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet1998;351:1755-62.
4. Campbell NRC, McAlister FA, Duong-Hua M, et al. Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement. Can J Cardiol 2007;23(10):783-787.
5. Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: A meta-analysis. Am J Med 2007;120:713-719.
6. Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCI versus comparable component-based therapy. Congest Heart Failure 2003;9:324-32.
7. Bramley TJ, Gerbino PP, Nightengale BS, et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006;23:239-45.
8. DiTusa L, Luzier AB, Jarosz DE, et al. Treatment of hypertension in a managed care setting. Am J Manag Care 2001;7:520-4.
9. Schweizer J, Hilsmann U, Neumann G, et al. Efficacy and safety of valsartan 160/HCTZ 25mg in fixed combination in hypertensive patients not controlled by candesartan 32mg plus HCTZ 25mg in free combination. Curr Med Res Opin 2007;23(11):2877-85.
10. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomized trials. BMJ 2003;326:1427-34.
11. ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet 2007;370:829-40.
12. McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT; for the SCRIP-HTN Investigators. A Randomized Trial of the Effect of Community Pharmacist and Nurse Care on Improving Blood Pressure Management in Patients With Diabetes Mellitus. Arch Int Med 2008;168(21):2355-2361.